Right -- I was just under the impression that they still called the trials "Phase 1" and "Phase 2" (as with Pona) even though everyone knows that the first trial is robust enough to demonstrate agent activity and the second will yield data that will justify approval.
I hadn't seen the term "Phase 1/2" before.
EDIT: Excuse me, but did someone just pay $10.18 premarket?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.